X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (66159) 66159
Newsletter (10764) 10764
Publication (6563) 6563
Newspaper Article (816) 816
Magazine Article (402) 402
Book Review (373) 373
Book Chapter (263) 263
Conference Proceeding (77) 77
Book / eBook (72) 72
Dissertation (60) 60
Trade Publication Article (52) 52
Transcript (43) 43
Web Resource (24) 24
Reference (19) 19
Paper (16) 16
Data Set (12) 12
Journal / eJournal (5) 5
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33271) 33271
antifungal agents (24791) 24791
index medicus (22875) 22875
antifungal agents - pharmacology (21437) 21437
antifungal agents - therapeutic use (19077) 19077
male (14597) 14597
female (13159) 13159
microbiology (12409) 12409
microbial sensitivity tests (11892) 11892
pharmacology & pharmacy (10604) 10604
animals (9994) 9994
adult (9134) 9134
research (8419) 8419
middle aged (8231) 8231
antifungal agents - administration & dosage (7425) 7425
antifungal activity (7336) 7336
infectious diseases (6543) 6543
mycoses (6453) 6453
antifungal agents - chemistry (6127) 6127
antifungal (5976) 5976
analysis (5614) 5614
fluconazole (5471) 5471
candida albicans - drug effects (5451) 5451
aged (5236) 5236
chemistry, medicinal (5177) 5177
mycology (4864) 4864
fungi (4732) 4732
treatment outcome (4546) 4546
health aspects (4529) 4529
biochemistry & molecular biology (4361) 4361
fungi - drug effects (4219) 4219
voriconazole (4113) 4113
candida - drug effects (3954) 3954
mycoses - drug therapy (3881) 3881
itraconazole (3879) 3879
candidiasis - drug therapy (3853) 3853
infections (3761) 3761
amphotericin-b (3743) 3743
drugs (3707) 3707
amphotericin b - therapeutic use (3664) 3664
anti-bacterial agents - pharmacology (3619) 3619
adolescent (3518) 3518
immunology (3359) 3359
infection (3359) 3359
in-vitro (3323) 3323
mice (3301) 3301
care and treatment (3269) 3269
universities and colleges (3203) 3203
antifungal agents - adverse effects (3179) 3179
epidemiology (3053) 3053
dermatology (3044) 3044
amphotericin b (2912) 2912
drug therapy (2838) 2838
child (2825) 2825
resistance (2799) 2799
antifungal agents - chemical synthesis (2747) 2747
candida albicans (2735) 2735
antimicrobial activity (2734) 2734
antibacterial (2641) 2641
molecular structure (2614) 2614
candida-albicans (2602) 2602
antifungal agents - isolation & purification (2599) 2599
fluconazole - therapeutic use (2591) 2591
biotechnology & applied microbiology (2581) 2581
structure-activity relationship (2555) 2555
risk factors (2493) 2493
drug resistance, fungal (2464) 2464
fungicides (2455) 2455
therapy (2453) 2453
aspergillosis - drug therapy (2450) 2450
candidiasis (2449) 2449
dose-response relationship, drug (2444) 2444
reports (2437) 2437
cancer (2427) 2427
fluconazole - pharmacology (2403) 2403
candida (2394) 2394
plant sciences (2355) 2355
derivatives (2316) 2316
medical research (2293) 2293
aspergillosis (2284) 2284
antibacterial activity (2273) 2273
chemistry, multidisciplinary (2264) 2264
susceptibility (2249) 2249
antifungal agents - pharmacokinetics (2243) 2243
diagnosis (2219) 2219
candidiasis - microbiology (2203) 2203
itraconazole - therapeutic use (2169) 2169
research article (2140) 2140
amphotericin b - pharmacology (2130) 2130
drug therapy, combination (2126) 2126
fungal-infections (2087) 2087
medicine, experimental (2087) 2087
agents (2085) 2085
fungal infections (2080) 2080
retrospective studies (2071) 2071
bacteria - drug effects (2044) 2044
chemistry, organic (1990) 1990
yeast (1973) 1973
immunocompromised host (1970) 1970
antibiotics (1966) 1966
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (39) 39
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Earth Sciences (Noranda) - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Mississauga - Stacks (2) 2
Royal Ontario Museum - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (73030) 73030
German (1297) 1297
French (960) 960
Japanese (711) 711
Russian (620) 620
Spanish (608) 608
Chinese (300) 300
Polish (196) 196
Italian (147) 147
Portuguese (132) 132
Dutch (88) 88
Czech (82) 82
Turkish (78) 78
Danish (43) 43
Ukrainian (43) 43
Hungarian (42) 42
Bulgarian (35) 35
Korean (32) 32
Romanian (21) 21
Swedish (19) 19
Hebrew (18) 18
Finnish (17) 17
Norwegian (17) 17
Persian (15) 15
Slovak (13) 13
Croatian (8) 8
Lithuanian (7) 7
Serbian (6) 6
Arabic (5) 5
Afrikaans (2) 2
Slovenian (2) 2
Thai (2) 2
Estonian (1) 1
Greek (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
1995, Molecular biology intelligence unit (Unnumbered), ISBN 9781570592621, 139
Book
1990, Handbook of experimental pharmacology, ISBN 9780387522326, Volume 96., xxv, 558
Book
2001, Advcances in protein chemistry, ISBN 0120342561, Volume 56., xi, 567 p., [4] p. of plates
Strategies to reduce medical uncertainty and build evidence have become critical to the advancement of medical knowledge and modern medical practice. As new... 
Drugs | Design | Methodology | Drug development | Industrial chemistry & manufacturing technologies
Book
Drug Testing and Analysis, ISSN 1942-7603, 10/2018, Volume 10, Issue 10, pp. 1554 - 1565
Journal Article
The Lancet, ISSN 0140-6736, 10/2003, Volume 362, Issue 9390, pp. 1142 - 1151
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. 1078 - 1089
Background & Aims We performed a genome-wide association study (GWAS) to identify genetic risk factors for drug-induced liver injury (DILI) from licensed drugs... 
Gastroenterology and Hepatology | Side Effect | Medication | Liver Damage | Anti-Fungal Agent | POPULATION | SUSCEPTIBILITY | RISK | TERBINAFINE | TICLOPIDINE | HEPATITIS | CLASS-I | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | ANTIGEN | Antifungal Agents - adverse effects | Naphthalenes - adverse effects | Humans | Middle Aged | Male | Sertraline - adverse effects | Fenofibrate - adverse effects | Chromosomes, Human, Pair 2 - genetics | Ticlopidine - adverse effects | Female | Odds Ratio | Chemical and Drug Induced Liver Injury - etiology | Platelet Aggregation Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Genes, MHC Class I - genetics | Chemical and Drug Induced Liver Injury - genetics | Terbinafine | Phenotype | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Alleles | HLA-A Antigens - genetics | Polymorphism, Single Nucleotide | Antidepressive Agents - adverse effects | Drugs | Medical research | Liver diseases | Liver | Genes | Genomics | Risk factors | Genetic polymorphisms | Analysis | Gastrointestinal diseases | Medicine, Experimental | Genetic research | Trade and professional associations | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | side effect | medication | anti-fungal agent | liver damage | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Gastroenterologi | Klinisk medicin
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S357 - S357
When rezafungin was dosed concomitantly with metformin, pitavastatin, caffeine, efavirenz, midazolam, digoxin, tacrolimus, repaglinide, and rosuvastatin, no... 
Analysis | Drug interactions | Antifungal agents | Cytochrome P-450 | Mycoses | Transplantation | Drug therapy, Combination | Efavirenz | Investigations | Hematopoietic stem cells | Caffeine
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article